NCT02736110

Withdrawn

Registry of Celution Device for the Processing of Adipose De...

Cytori Therapeutics Source

ClinicalTrials.gov

Compare

Other study identifiers

Sponsor study identifier

RELIEVE

Study Type

observational

Actual enrollment (reported)

0

Locations

0 countries

Sites

N/A

Timeline

Study Start

September 2014

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

September 2016

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Study Completion

July 2017

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Brief Summary

This registry study will compile information from patients that are scheduled to receive or have received Adipose Derived Regenerative Cells (ADRCs) prepared by the Celution device to treat osteoarthritis in the knee.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: withdrawn
Actual enrollment (reported): 0 participants
Study completion date: July 2017
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Listed locations: 0 countries · 0 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
September 2014
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
March 15, 2016
Actual (reported)
First Posted
April 13, 2016
Actual (reported)
Primary Completion
September 2016
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
July 2017
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated: April 13, 2016
Status Verified: April 2016
Last Update Submitted: April 12, 2016

Conditions

Osteoarthritis

Keywords

Osteoarthritis, knee

Outcome Measures

Primary Outcomes (1)

Change in knee pain as assessed by the knee injury and osteoarthritis outcome score (KOOS)
90 days

Secondary Outcomes (6)

Change in knee pain as assessed by the knee injury and osteoarthritis outcome score (KOOS)
Days 7, 30, 180 and 365
Change in knee pain assessed by VAS Assessments
Days 7, 30, 90, 180 and 365
Change in knee function as assessed by the Lysholm Knee Scoring Scale
Days 7, 30, 90, 180 and 365
Change in WORMS scoring (Whole Organ MRI of the knee)
Days 180 and 365
Change in knee function as measured by Tegner Activity Scale
Days 7, 30, 90, 180 and 365
+1 more secondary outcomes

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Patients that are schedule to receive or have received Adipose Derived Regenerative Cells (ADRCs) prepared by the Celution device to treat osteoarthritis in the knee.

You may qualify if:

Males or females \> 18 years of age

Sponsors & Collaborators

Cytori Therapeutics
Industrylead

MeSH Terms

Conditions

OsteoarthritisOsteoarthritis, Knee

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

Steven Kesten
Cytori Therapeutics
STUDY CHAIR

Enrollment

0 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: CASE ONLY
Time Perspective: PROSPECTIVE
Target Duration: 1 Year
Sponsor Type: INDUSTRY
Responsible Party: SPONSOR

Study Record Dates

First Submitted

March 15, 2016

First Posted

April 13, 2016

Study Start

September 2014

Date type not reported

This date has not been verified as actual or estimated.

NCT02241408

Outcomes Data of Adipose Stem Cells to Treat Osteoarthritis

Unknown

NCT02276833

Use of Autologous Adipose-Derived Stromal Vascular Fraction to Treat Osteoarthritis of the Knee

Phase 1Completed

NCT02641860

Clinical Trial of Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells Therapy for Knee Osteoarthritis

Phase 1Completed

NCT02405793

Meloxicam SoluMatrix® Capsules vs Meloxicam Tablets to Treat Osteoarthritis Pain

Phase 2Withdrawn

NCT01739504

Autologous Adipose-Derived Stromal Cells Delivered Intra-articularly in Patients With Osteoarthritis.

Not ApplicableTerminated

NCT02844751

Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Knee

Phase 2Recruiting

Diagnosis of osteoarthritis in one or both knees with Kellgren Lawrence grade ≥ 2 at x-ray evaluation or MRI findings of degenerative changes

Pain with or without swelling in the affected area for \>4 months

You may not qualify if:

Know spine or disc disease or symptomatic nerve impingement contributing to pain in the affected limb
History of documented nerve damage in the affected limb
Pregnant or lactating status. Pregnancy as determined by a positive pregnancy test prior to procedure.

Contact the study team to confirm eligibility.

Primary Completion

September 2016

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Study Completion

July 2017

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated

April 13, 2016

Record last verified: 2016-04

Data Sharing

IPD Sharing: Will share

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT02736110
Data provider: ClinicalTrials.gov
Source updated: 2016-04-13
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:19:45 UTC

Study Stopped

Registry of Celution Device for the Processing of Adipose Derived Regenerative Cells (ADRCs) to Treat Osteoarthritis

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (6)

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (6)

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record